JP2016532714A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016532714A5 JP2016532714A5 JP2016540431A JP2016540431A JP2016532714A5 JP 2016532714 A5 JP2016532714 A5 JP 2016532714A5 JP 2016540431 A JP2016540431 A JP 2016540431A JP 2016540431 A JP2016540431 A JP 2016540431A JP 2016532714 A5 JP2016532714 A5 JP 2016532714A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- hydrate
- cancer
- polymorphic form
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- MWAXYALYIRECDP-YFKPBYRVSA-O N[C@@H](CCCNCC(N)=[NH2+])C(O)=O Chemical compound N[C@@H](CCCNCC(N)=[NH2+])C(O)=O MWAXYALYIRECDP-YFKPBYRVSA-O 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361874823P | 2013-09-06 | 2013-09-06 | |
| US61/874,823 | 2013-09-06 | ||
| PCT/US2014/054354 WO2015035212A1 (en) | 2013-09-06 | 2014-09-05 | Alpha-tea salt forms: compositions and uses for treating disease |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019231273A Division JP2020063294A (ja) | 2013-09-06 | 2019-12-23 | アルファ−ｔｅａ塩形態：疾患を処置するための組成物および使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016532714A JP2016532714A (ja) | 2016-10-20 |
| JP2016532714A5 true JP2016532714A5 (enExample) | 2017-10-12 |
| JP6675985B2 JP6675985B2 (ja) | 2020-04-08 |
Family
ID=51570908
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016540431A Active JP6675985B2 (ja) | 2013-09-06 | 2014-09-05 | アルファ−ｔｅａ塩形態：疾患を処置するための組成物および使用 |
| JP2019231273A Pending JP2020063294A (ja) | 2013-09-06 | 2019-12-23 | アルファ−ｔｅａ塩形態：疾患を処置するための組成物および使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019231273A Pending JP2020063294A (ja) | 2013-09-06 | 2019-12-23 | アルファ−ｔｅａ塩形態：疾患を処置するための組成物および使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US10370350B2 (enExample) |
| EP (1) | EP3041831B1 (enExample) |
| JP (2) | JP6675985B2 (enExample) |
| AU (1) | AU2014318014C1 (enExample) |
| CA (1) | CA2922375C (enExample) |
| DK (1) | DK3041831T3 (enExample) |
| ES (1) | ES2766324T3 (enExample) |
| PL (1) | PL3041831T3 (enExample) |
| WO (1) | WO2015035212A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2014318014C1 (en) | 2013-09-06 | 2018-11-15 | Research Development Foundation | Alpha-tea salt forms: compositions and uses for treating disease |
| GB201701194D0 (en) | 2017-01-24 | 2017-03-08 | Capella Bioscience Ltd | Antigen binding molecules that bind light |
| CN107050432B (zh) * | 2017-02-28 | 2019-09-10 | 上海交通大学医学院 | 胃泌素在制备诊断和治疗乳腺癌药物中的应用 |
| US11312781B2 (en) | 2018-01-24 | 2022-04-26 | Capella Bioscience Ltd. | Antigen binding molecules that bind LIGHT |
| EP3646873A1 (en) * | 2018-10-31 | 2020-05-06 | Aprofol AG | Folate salts |
| CN111635390A (zh) * | 2020-06-30 | 2020-09-08 | 江南大学 | 一种低泡型α-生育酚表面活性剂及其制备方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS4629734Y1 (enExample) | 1968-04-23 | 1971-10-14 | ||
| US4861580A (en) | 1985-10-15 | 1989-08-29 | The Liposome Company, Inc. | Composition using salt form of organic acid derivative of alpha-tocopheral |
| JP2634047B2 (ja) * | 1985-10-15 | 1997-07-23 | ザ リポソ−ム カンパニ−，インコ−ポレイテツド | アルファトコフェロールをベースとした小胞体 |
| US6770672B1 (en) | 1998-09-23 | 2004-08-03 | Research Development Foundation | Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |
| RU2232758C2 (ru) * | 1998-09-23 | 2004-07-20 | Рисерч Дивелопмент Фаундейшн | Токоферолы, токотриенолы и другие производные хромана и боковых цепей и способы лечения с их использованием |
| US6703384B2 (en) | 1998-09-23 | 2004-03-09 | Research Development Foundation | Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |
| AU2001236805B2 (en) | 2000-02-11 | 2005-07-14 | Research Development Foundation | Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |
| ATE468109T1 (de) * | 2001-12-19 | 2010-06-15 | Res Dev Foundation | Liposomale abgabe von verbindungen auf vitamin-e- basis |
| AU2014318014C1 (en) | 2013-09-06 | 2018-11-15 | Research Development Foundation | Alpha-tea salt forms: compositions and uses for treating disease |
-
2014
- 2014-09-05 AU AU2014318014A patent/AU2014318014C1/en active Active
- 2014-09-05 EP EP14767252.1A patent/EP3041831B1/en active Active
- 2014-09-05 PL PL14767252T patent/PL3041831T3/pl unknown
- 2014-09-05 DK DK14767252.1T patent/DK3041831T3/da active
- 2014-09-05 WO PCT/US2014/054354 patent/WO2015035212A1/en not_active Ceased
- 2014-09-05 US US14/916,271 patent/US10370350B2/en active Active
- 2014-09-05 JP JP2016540431A patent/JP6675985B2/ja active Active
- 2014-09-05 ES ES14767252T patent/ES2766324T3/es active Active
- 2014-09-05 CA CA2922375A patent/CA2922375C/en active Active
-
2019
- 2019-06-18 US US16/443,911 patent/US10934267B2/en active Active
- 2019-12-23 JP JP2019231273A patent/JP2020063294A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016532714A5 (enExample) | ||
| JP7536064B2 (ja) | 抗癌活性及び抗増殖活性を呈する２－アミノピリミジン－６－オン及び類似体 | |
| CN112839715B (zh) | 抑制shp2活性化合物的制造方法 | |
| JP3834263B2 (ja) | Ｃｏｘ−２阻害薬の合成方法 | |
| JP5998145B2 (ja) | ピリミジン誘導体の製造プロセス | |
| JP2020528907A5 (enExample) | ||
| CN107427523B (zh) | 平滑肌肉瘤的靶向疗法 | |
| TWI578983B (zh) | 用於治療癌症的化合物及組成物 | |
| ES2660215T3 (es) | Potenciador de efecto antitumoral que comprende un compuesto de imidazooxazina | |
| BR112021012682A2 (pt) | Inibidor de fak e combinação de fármaco do mesmo | |
| JPWO2020075790A1 (ja) | Ｓｔｉｎｇ作動化合物 | |
| CN109863137B (zh) | Lsd1抑制剂及其医学用途 | |
| JP2012504628A5 (enExample) | ||
| RU2014101626A (ru) | Полиморфы 2-амид 1-({4-метил-5-[2-(2, 2, 2-трифтор-1, 1-диметил-этил)-пиридин-4-ил]тиазол-2-ил}амида) (s)-пирролидин-1, 2-дикарбоновой кислоты | |
| JP2018509404A5 (enExample) | ||
| CN118434748A (zh) | 一种六元并六元化合物、制备方法、药物组合物和应用 | |
| JP2014524476A5 (enExample) | ||
| CN108289895B (zh) | 噻吩并嘧啶衍生物及其用途 | |
| WO2016078160A1 (zh) | 胞苷衍生物及其应用 | |
| JP2019509295A (ja) | レチノイン酸系化合物、その製造方法、中間体及び応用 | |
| WO2016140501A1 (en) | Pyridine n-oxide for enhancer of zeste homolog 2 inhibitors | |
| CA2423220A1 (en) | Modified prodrug forms of ap/amp | |
| ES2782113T3 (es) | Compuestos de quinolina fusionados como inhibidores de PI3K/mTor | |
| JP2019506382A (ja) | 癌及びウイルスを阻害するための化合物 | |
| JPWO2021007307A5 (enExample) |